Key result
Unprotected left main PCI shows ~44% lower 3-year MACCE in 2017 compared to 2005.
Why the study?
The use of PCI to treat unprotected left main coronary artery disease expanded rapidly over the past decade, motivating a description of nationwide trends in clinical practice and outcomes.
Observational (n=4,085)
Yes
Answers are grounded in this paper and cite their sources.
Supports the growing real-world safety of contemporary left main PCI, though observational design leaves open the relative causal contributions of imaging, radial access, and newer-generation stents.
Background The use of percutaneous coronary intervention (PCI) to treat unprotected left main coronary artery disease has expanded rapidly in the past decade. We aimed to describe nationwide trends in clinical practice and outcomes after PCI for left main coronary artery disease. Methods and Results Patients (n=4085) enrolled in the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) as undergoing PCI for left main coronary artery disease from 2005 to 2017 were included. A count regression model was used to analyze time‐related differences in procedural characteristics. The 3‐year major adverse cardiovascular and cerebrovascular event rate defined as death, myocardial infarction, stroke, and repeat revascularization was calculated with the Kaplan‐Meier estimator and Cox proportional hazard model. The number of annual PCI procedures grew from 121 in 2005 to 589 in 2017 (389%). The increase was greater for men (479%) and individuals with diabetes (500%). Periprocedural complications occurred in 7.9%, decreasing from 10% to 6% during the study period. A major adverse cardiovascular and cerebrovascular event occurred in 35.7% of patients, falling from 45.6% to 23.9% (hazard ratio, 0.56; 95% CI, 0.41–0.78; P =0.001). Radial artery access rose from 21.5% to 74.2% and intracoronary diagnostic procedures from 14.0% to 53.3%. Use of bare‐metal stents and first‐generation drug‐eluting stents fell from 19.0% and 71.9%, respectively, to 0, with use of new‐generation drug‐eluting stents increasing to 95.2%. Conclusions Recent changes in clinical practice relating to PCI for left main coronary artery disease are characterized by a 4‐fold rise in procedures conducted, increased use of evidence‐based adjunctive treatment strategies, intracoronary diagnostics, newer stents, and more favorable outcomes.
No takes yet. Share an insight, caveat, or question.
Mohammad et al. (2022) conducted an observational in Unprotected left main coronary artery disease (n=4,085). Percutaneous coronary intervention of unprotected left main coronary artery (2017 cohort) vs. 2005 cohort was evaluated on Major adverse cardiovascular and cerebrovascular event (MACCE: death from any cause, myocardial infarction, stroke, or repeat revascularization) within 3 years (HR 0.56, 95% CI 0.41-0.78, p=0.001). Percutaneous coronary intervention for unprotected left main disease saw a 44% reduction in 3-year MACCE from 45.6% in 2005 to 23.9% in 2017.
Synapse has enriched 10 related papers. Consider them for comparative context: